
PubChem’s acetyl octapeptide-3 record lists SNAP-8/SNAP8 as synonyms and gives the eight-residue sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂. Here, Ac denotes N-terminal acetylation and NH₂ denotes a C-terminal amide. This identifies the structure listed in that database record; it does not verify the contents of a particular research-material batch.[1]
For evaluation, separate three questions: what structure is listed, what an analytical method measures, and what a biological experiment demonstrates. The sources reviewed below do not directly test SNAP-8 binding to SNARE proteins or its effect on cellular release. That is a limit of this source set, not a conclusion that such evidence does not exist elsewhere.
What structure is listed for acetyl octapeptide-3?
The PubChem record lists Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂: eight amino-acid residues with an acetylated N-terminus and an amidated C-terminus.[1]
Read this as an identity reference. A document that repeats the sequence shows what material is claimed; it does not, by itself, show what was measured in a sample. For a particular batch, the next review question is whether batch-matched analytical documentation supports that claimed identity.
How does it differ from acetyl hexapeptide-8 and SNAP-25?

PubChem’s acetyl hexapeptide-8 record lists Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂. Comparing the two entries shows six residues versus eight: the octapeptide entry includes Ala-Asp after the shared Glu-Glu-Met-Gln-Arg-Arg sequence. This is a structural comparison, not evidence of equivalent activity.[1][2]
SNAP-25 is a protein discussed in the separate mimic study below; the listed acetyl octapeptide-3 structure is a short peptide. Neither a similar name nor a sequence comparison demonstrates that the short peptide binds SNAP-25 or reproduces its activity.[1][3]
| Identity reference | Listed structure or description | Supported conclusion |
|---|---|---|
| Acetyl octapeptide-3, PubChem CID 76283482 | Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂ | The record lists an eight-residue, N-acetylated, C-terminally amidated peptide and includes SNAP-8/SNAP8 as synonyms.[1] |
| Acetyl hexapeptide-8, PubChem CID 71587772 | Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂ | The record lists a six-residue peptide without the octapeptide entry’s Ala-Asp residues.[2] |
| SNAP-25 in the 1997 mimic study | The protein whose C-terminal sequence informed a separate peptide | A study involving a SNAP-25 mimic must be evaluated for the actual peptide tested.[3] |
What does the SNAP-8 analytical paper test?

The abstract of the 2020 paper describes a liquid chromatography–tandem mass spectrometry (LC-MS/MS) method for quantifying acetyl octapeptide-3, applied to a biodegradable microneedle patch. It reports analytical performance measures including linearity, quantification limit, repeatability, and accuracy.[4]
Those reported endpoints concern measurement. The reviewed abstract does not describe a direct SNARE-binding experiment or a cellular exocytosis test. It therefore supports an analytical-method summary, not a demonstrated biological mechanism.[4]
For example, consider a claim that this paper “proves SNAP-8 inhibits SNARE-mediated release.” The available abstract identifies the analyte, analytical technique, application, and method-performance endpoints. What is missing for that claim is a direct interaction measurement and a relevant biological release endpoint. The defensible conclusion is that the abstract describes quantification—not that it demonstrates release inhibition. Full method details and suitability for a different sample matrix remain outside this abstract-level review.
What does the separate SNAP-25-mimic study show?
The 1997 study describes ESUP-A, a 20-residue peptide patterned after the C-terminal sequence of SNAP-25. Its abstract reports secretory-vesicle docking and exocytosis findings in chromaffin cells and states that the mechanism remained elusive.[3]
This 20-mer is not the eight-residue acetyl octapeptide-3 listed in PubChem. The experimental result belongs to the peptide and cellular conditions studied; it cannot establish a mechanism for SNAP-8.[1][3]
| Evidence item | What the reviewed material supports | What remains unanswered for SNAP-8 |
|---|---|---|
| Two PubChem records | Listed sequences and terminal chemistry | Whether a particular batch matches either record |
| 2020 LC-MS/MS abstract | An analytical quantification method and reported performance measures | Direct SNARE binding or a cellular release effect |
| 1997 SNAP-25-mimic abstract | Cellular findings for a different, 20-residue peptide | Whether acetyl octapeptide-3 produces a comparable result or shares a mechanism |
What evidence would test the proposed mechanism?
Within the four consulted records and abstracts, direct SNAP-8/SNARE binding and transmitter-release effects were not tested. Treat the proposed mechanism as an unestablished hypothesis within this review.
For evaluating a future mechanism study, use these questions:
- Test material: Was the tested peptide identified, including its sequence, terminal chemistry, and analytical documentation?
- Direct interaction: Did the study measure binding to specified SNARE components or an effect on SNARE-complex interaction or assembly?
- Cellular endpoint: Did it measure a relevant release or exocytosis endpoint, with conditions reported clearly?
- Controls: Could the design distinguish the proposed interaction from nonspecific effects or loss of cell viability?
- Reproducibility: Was the finding reproduced across experiments or independently?
These are proposed review criteria, not results supplied by the cited papers. A useful mechanism claim must connect the identified test material to a measured interaction and an interpretable biological endpoint. An analytical concentration result alone leaves that connection unanswered.
Related research: Peptide Identity Beyond the Product Name: Sequences, Fragments, Modifications, and Salt Forms; How to Read a Peptide COA: Purity, Identity, Quantity and Red Flags; Peptide Stability Claims: What Batch-Specific Evidence Should Support Them.
参考来源
- PubChem: Acetyl octapeptide-3, CID 76283482
- PubChem: Acetyl hexapeptide-8, CID 71587772
- A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells
- Method development for acetyl octapeptide-3 analysis by liquid chromatography-tandem mass spectrometry
Research Use Only Disclaimer
This article is for laboratory research and analytical education only. It is not a validated experimental protocol or medical or veterinary treatment advice. It provides no instructions for administering the discussed material to humans or animals; the material is not for such administration.